Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

Fereberger, W; Leb, G; Goebel, R; Samonigg, H; Robier, FP.
The current status of scintigraphy in oncology (author's transl)
ACTA MED AUST. 1981; 8(3): 88-92.
Web of Science PubMed

 

Co-authors Med Uni Graz
Samonigg Hellmut
Altmetrics:

Dimensions Citations:

Plum Analytics:
Abstract:
The clinical usefulness of tumor scanning methods is discussed under the practical considerations of tumor screening, determination of tumor size and noninvasive tumor staging as well as diagnostic follow-up after therapy. Scintigraphy as a primary diagnostic tool is mainly restricted to suspicious enlargements of the thyroid gland whereas scintigraphy with 67Ga-citrate in Hodgkin's disease and bone scintigraphy with 99mTc-phosphates in tumors with tendencies to early bone metastases are widely used non-invasive diagnostic means for the evaluation of tumor propagation. Post therapy conversion of positive findings is of less predictive value than than persistence of a positive scan. Some results of the literature are discussed with our own experiences.
Find related publications in this database (using NLM MeSH Indexing)
Antineoplastic Agents - therapeutic use
Diagnosis, Differential - therapeutic use
Humans - therapeutic use
Neoplasm Metastasis - therapeutic use
Neoplasms - radionuclide imaging

© Med Uni GrazImprint